117 related articles for article (PubMed ID: 2438051)
21. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
Allen PB; Morgan GJ; Wiedemann LM
Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
[TBL] [Abstract][Full Text] [Related]
22. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
[TBL] [Abstract][Full Text] [Related]
23. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
Shore SK; Bogart SL; Reddy EP
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
[TBL] [Abstract][Full Text] [Related]
24. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
Konopka JB; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte ON
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4049-52. PubMed ID: 3012546
[TBL] [Abstract][Full Text] [Related]
25. Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties.
Davis RL; Konopka JB; Witte ON
Mol Cell Biol; 1985 Jan; 5(1):204-13. PubMed ID: 4039028
[TBL] [Abstract][Full Text] [Related]
26. Immunological detection of proteins phosphorylated at tyrosine in cells stimulated by growth factors or transformed by retroviral-oncogene-coded tyrosine kinases.
Di Renzo MF; Ferracini R; Naldini L; Giordano S; Comoglio PM
Eur J Biochem; 1986 Jul; 158(2):383-91. PubMed ID: 2426107
[TBL] [Abstract][Full Text] [Related]
27. Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine.
Kipreos ET; Lee GJ; Wang JY
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1345-9. PubMed ID: 2434953
[TBL] [Abstract][Full Text] [Related]
28. Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products.
Groffen J; Heisterkamp N; Reynolds FH; Stephenson JR
Nature; 1983 Jul 14-20; 304(5922):167-9. PubMed ID: 6191223
[TBL] [Abstract][Full Text] [Related]
29. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
30. Transformation of murine bone marrow cells with combined v-raf-v-myc oncogenes yields clonally related mature B cells and macrophages.
Principato M; Cleveland JL; Rapp UR; Holmes KL; Pierce JH; Morse HC; Klinken SP
Mol Cell Biol; 1990 Jul; 10(7):3562-8. PubMed ID: 2162474
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells.
Bustelo XR; Barbacid M
Science; 1992 May; 256(5060):1196-9. PubMed ID: 1375396
[TBL] [Abstract][Full Text] [Related]
32. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
Jacobsen EA; Ananieva O; Brown ML; Chang Y
J Immunol; 2006 Jun; 176(11):6831-8. PubMed ID: 16709843
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of heavy-chain class switching and switch region deletion in an Abelson virus-transformed cell line.
DePinho R; Kruger K; Andrews N; Lutzker S; Baltimore D; Alt FW
Mol Cell Biol; 1984 Dec; 4(12):2905-10. PubMed ID: 6098827
[TBL] [Abstract][Full Text] [Related]
34. Gamma 2b provides only some of the signals normally given via mu in B cell development.
Kurtz BS; Witte PL; Storb U
Int Immunol; 1997 Mar; 9(3):415-26. PubMed ID: 9088980
[TBL] [Abstract][Full Text] [Related]
35. In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homolog.
Ponticelli AS; Whitlock CA; Rosenberg N; Witte ON
Cell; 1982 Jul; 29(3):953-60. PubMed ID: 6185233
[TBL] [Abstract][Full Text] [Related]
36. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.
Konopka JB; Watanabe SM; Witte ON
Cell; 1984 Jul; 37(3):1035-42. PubMed ID: 6204766
[TBL] [Abstract][Full Text] [Related]
37. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.
Gong L; Unnikrishnan I; Raghavan A; Parmar K; Rosenberg N
J Virol; 2004 Feb; 78(4):1636-44. PubMed ID: 14747529
[TBL] [Abstract][Full Text] [Related]
38. Arrested development: understanding v-abl.
Kerr LD
Bioessays; 1994 Jul; 16(7):453-5. PubMed ID: 7945272
[TBL] [Abstract][Full Text] [Related]
39. Induction by some protein kinase inhibitors of differentiation of a mouse megakaryoblastic cell line established by coinfection with Abelson murine leukemia virus and recombinant SV40 retrovirus.
Honma Y; Okabe-Kado J; Kasukabe T; Hozumi M; Kajigaya S; Suda T; Miura Y
Cancer Res; 1991 Sep; 51(17):4649-55. PubMed ID: 1651810
[TBL] [Abstract][Full Text] [Related]
40. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity.
Kloetzer W; Kurzrock R; Smith L; Talpaz M; Spiller M; Gutterman J; Arlinghaus R
Virology; 1985 Jan; 140(2):230-8. PubMed ID: 2982232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
